Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Fletcher

Showing results (261-270 of 326) with videos related to

Pageof 33
Sort By:
The Journal of Infectious Diseases|November 9, 2000
Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study TeamW T Shearer, R J Israel, S Starr, et al.
Cell Reports|August 17, 2022
Spatially resolved deconvolution of the fibrotic niche in lung fibrosisMichael Eyres, Joseph A Bell, Elizabeth R Davies, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2006
Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140)William T Shearer, Jaime G DeVille, Pearl M Samson, et al.
ERJ Open Research|July 28, 2020
Time taken from primary care referral to a specialist centre diagnosis of idiopathic pulmonary fibrosis: an opportunity to improve patient outcomes?Christopher J Brereton, Timothy Wallis, Michelle Casey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 13, 2020
Brief Report: Sex Differences in Outcomes for Individuals Presenting for Third-Line Antiretroviral TherapyCatherine Godfrey, Michael D Hughes, Justin Ritz, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|May 4, 2026
A Pilot Evaluation of a Telemedicine Pharmacist-Physician Management Model to Increase Access to Medication for Alcohol and Opioid Use Disorders for Rural VeteransAmy J Kennedy, Madeline C Frost, Carol A Malte, et al.
BMC Complementary Medicine and Therapies|April 10, 2021
In-vitro Immunomodulatory activity of Azadirachta indica A.Juss. Ethanol: water mixture against HIV associated chronic CD4<sup>+</sup> T-cell activation/ exhaustionOmalla A Olwenyi, Bannet Asingura, Prossy Naluyima, et al.
Scientific Reports|May 10, 2024
In-vitro and in-vivo assessment of nirmatrelvir penetration into CSF, central nervous system cells, tissues, and peripheral blood mononuclear cellsSean N Avedissian, Johid R Malik, Anthony T Podany, et al.
The European Respiratory Journal|February 4, 2022
Temporal progression of mediastinal lymphadenopathy in idiopathic pulmonary fibrosisTim J M Wallis, Eyjólfur Gudmundsson, Katarina Pontoppidan, et al.
Frontiers in Pharmacology|August 20, 2016
Etravirine Pharmacokinetics in HIV-Infected Pregnant WomenNikki Mulligan, Stein Schalkwijk, Brookie M Best, et al.
Pageof 33

Showing results (261-270 of 326) with videos related to

Sort By:
Pageof 33
The Journal of Infectious Diseases|November 9, 2000
Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study TeamW T Shearer, R J Israel, S Starr, et al.
Cell Reports|August 17, 2022
Spatially resolved deconvolution of the fibrotic niche in lung fibrosisMichael Eyres, Joseph A Bell, Elizabeth R Davies, et al.
The Journal of Allergy and Clinical Immunology|August 8, 2006
Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140)William T Shearer, Jaime G DeVille, Pearl M Samson, et al.
ERJ Open Research|July 28, 2020
Time taken from primary care referral to a specialist centre diagnosis of idiopathic pulmonary fibrosis: an opportunity to improve patient outcomes?Christopher J Brereton, Timothy Wallis, Michelle Casey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 13, 2020
Brief Report: Sex Differences in Outcomes for Individuals Presenting for Third-Line Antiretroviral TherapyCatherine Godfrey, Michael D Hughes, Justin Ritz, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|May 4, 2026
A Pilot Evaluation of a Telemedicine Pharmacist-Physician Management Model to Increase Access to Medication for Alcohol and Opioid Use Disorders for Rural VeteransAmy J Kennedy, Madeline C Frost, Carol A Malte, et al.
BMC Complementary Medicine and Therapies|April 10, 2021
In-vitro Immunomodulatory activity of Azadirachta indica A.Juss. Ethanol: water mixture against HIV associated chronic CD4<sup>+</sup> T-cell activation/ exhaustionOmalla A Olwenyi, Bannet Asingura, Prossy Naluyima, et al.
Scientific Reports|May 10, 2024
In-vitro and in-vivo assessment of nirmatrelvir penetration into CSF, central nervous system cells, tissues, and peripheral blood mononuclear cellsSean N Avedissian, Johid R Malik, Anthony T Podany, et al.
The European Respiratory Journal|February 4, 2022
Temporal progression of mediastinal lymphadenopathy in idiopathic pulmonary fibrosisTim J M Wallis, Eyjólfur Gudmundsson, Katarina Pontoppidan, et al.
Frontiers in Pharmacology|August 20, 2016
Etravirine Pharmacokinetics in HIV-Infected Pregnant WomenNikki Mulligan, Stein Schalkwijk, Brookie M Best, et al.
Pageof 33